TL;DR
Supreme Brain assigns NYM -1.5 a 60.4% win probability against Cincinnati, a full 10.4 percentage points above the 50.0% market-implied probability at +125 odds. That gap translates to +5.0% expected value on the current price, enough to warrant a 0.29-unit quarter-Kelly stake. The edge exists despite New York carrying a -10 run differential over their last 10 games—a stretch that has depressed the line and created plus-money runline value where the market sees a cold team. Cincinnati arrives with eight players on the injury report compared to New York's thirteen, but the model still favors the Mets to win by multiple runs. The thesis is simple: when a quantitative edge this wide opens on a runline, you take it, even if recent form makes the bet feel uncomfortable. That discomfort is often where value lives.
Supreme Brain assigns NYM -1.5 a 60.4% win probability versus a 50.0% market-implied probability at +125 odds—a 10.4-point gap that rarely appears on runlines without a reason. The reason here is recent form: New York has posted a -10 run differential over their last 10 games, enough to scare off casual money and push this line into plus-money territory.
The thesis is straightforward: a 60.4% model probability against 50% implied odds yields +5.0% expected value, and when that edge appears on a runline, you lean in—even when the team in question has been ice-cold over the last week and a half.
Why we like it
- The Supreme Brain model pegs this at 60.4% to cover, which translates to a fair price around +66. At +125, you're getting +5.0% expected value on the full-vig market (+3.5% EV after accounting for juice). That's a material edge, and it sizes to a 0.29-unit quarter-Kelly stake at current bankroll levels. When the model sees a double-digit percentage-point gap between its probability and the market's, the historical hit rate on these spots justifies the exposure.
- New York's -10 run differential over their last 10 games is precisely why this line exists at plus money. The market has overreacted to a cold stretch, creating runline value where recency bias has done the pricing work for you. Supreme Brain's caveat acknowledges the recent form but still assigns better-than-even odds to a multi-run win, suggesting the underlying talent and matchup dynamics haven't shifted as much as the scoreboard suggests.
- Cincinnati enters with eight players on the injury report compared to New York's thirteen, but depth charts tell only part of the story. The Mets' injury list has been baked into their performance over the last 10 games—this isn't new information that should move the line further. The model accounts for roster availability and still sees a 60.4% path to a two-run margin, which implies the healthy pieces in New York's lineup and rotation are enough to exploit Cincinnati's own depleted roster.
How this loses
If New York's recent offensive drought extends into this game—particularly if they fail to score more than three runs—the runline becomes a long shot regardless of pitching performance. The -10 run differential over the last 10 games isn't just bad luck; it's a measurable offensive collapse. If that collapse continues, even a quality start won't be enough to cover a two-run margin. Watch the first three innings: if the Mets go scoreless through the order's first turn, the live probability will tilt sharply away from this number.
Plus-money runlines on model favorites don't grow on trees, especially when the edge clocks in at +5.0%. The market has priced in New York's recent struggles; Supreme Brain suggests they haven't priced in enough.
